Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES1 | P23141 | 5/20 | 0.46 |
| ▸ | CES2 | O00748 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | DAO | P14920 | 1/20 | 0.46 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.42 |
| ▸ | CA2 | P00918 | 3/20 | 0.42 |
| ▸ | CA12 | O43570 | 3/20 | 0.42 |
| ▸ | CA1 | P00915 | 3/20 | 0.42 |
| ▸ | CA9 | Q16790 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PARP1 | P09874 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17801512 | 0.87 | SMN1; SMN2 (0.50) | ALDH1A1MAPTL3MBTL1MAPK1KDM4E | |
| SCHEMBL7789534 | 0.84 | CES2 (0.56) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL5682300 | 0.82 | CES1 (0.52) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL9091946 | 0.82 | CYP2C19 (0.50) | CES1CES2TSHRALDH1A1DAO | |
| SCHEMBL28464639 | 0.80 | ALDH1A1 (0.52) | CES1CES2ALDH1A1TDP1MAPT | |
| SCHEMBL5961932 | 0.80 | ALOX15 (0.52) | CES1CES2TSHRALDH1A1CA2 | |
| SCHEMBL3140047 | 0.80 | CES2 (0.48) | CES1CES2ALDH1A1CA2CA1 | |
| SCHEMBL28252458 | 0.80 | CES2 (0.48) | CES1CES2ALDH1A1CA2CA1 | |
| SCHEMBL5046739 | 0.78 | CES2 (0.55) | CES1CES2TSHRALDH1A1TDP1 | |
| SCHEMBL28468682 | 0.78 | CES2 (0.55) | CES1CES2L3MBTL1PARP1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023155368-A1 | CARBENE CO-GRAFTED MODIFIED FABRIC, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 苏州大学 | 2023-08-24 | — | — | WO | claimed |
| CN-115385948-A | Spiro-dihydrobenzothiole bisoxazoline compound, preparation method and application thereof | 中国科学院上海有机化学研究所 | 2022-11-25 | — | — | CN | claimed |
| CN-121974832-A | Sulfonate synthesis method based on flow photochemistry technology | 绍兴文理学院 | 2026-05-05 | — | — | CN | disclosed |
| US-12582752-B2 | Medical device and method for manufacturing same | TERUMO KABUSHIKI KAISHA (JP) | 2026-03-24 | — | — | US | disclosed |
| US-12054564-B2 | Medical device and method for manufacturing same | TERUMO KABUSHIKI KAISHA (JP) | 2024-08-06 | — | — | US | disclosed |
| EP-4005794-B1 | MEDICAL INSTRUMENT AND METHOD FOR MANUFACTURING SAME | TERUMO CORP (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-20240076796-A1 | PULSE METHOD FOR THE ELECTRODEPOSITION OF CONDUCTIVE POLYMER | Heraeus Medevio GmbH & Co. KG (DE) | 2024-03-07 | — | — | US | disclosed |
| CN-116925021-A | Dehydrocostuslactone alkylated derivative and salt thereof, pharmaceutical composition and application thereof | 洛阳尚德药缘科技有限公司 | 2023-10-24 | — | — | CN | disclosed |
| WO-2023155368-A1 | CARBENE CO-GRAFTED MODIFIED FABRIC, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF | 苏州大学 | 2023-08-24 | — | — | WO | disclosed |
| CN-114920645-B | Synthesis method of alpha-methoxy methyl acetate derivative | 常州大学 | 2023-07-18 | — | — | CN | disclosed |
| CN-116375771-A | Preparation method of chiral iron complex | 浙江九洲药业股份有限公司 | 2023-07-04 | — | — | CN | disclosed |
| US-20030130112-A1 | Solid support dirhodium catalyst compositions and methods for making and using same | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE | 2003-07-10 | — | — | US | disclosed |
| US-20030130536-A1 | Dirhodium catalyst compositions and methods for using same | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2003-07-10 | — | — | US | disclosed |
| WO-2003018183-A2 | DIRHODIUM CATALYST COMPOSITIONS AND METHODS FOR USING SAME | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2003-03-06 | — | — | WO | disclosed |
| WO-2003018184-A2 | SOLID SUPPORT DIRHODIUM CATALYST COMPOSITIONS AND METHODS FOR MAKING AND USING SAME | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2003-03-06 | — | — | WO | disclosed |
| US-20020183535-A1 | Metal catalysts and methods for making and using same | DAVIES HUW M L (US) | 2002-12-05 | — | — | US | disclosed |
| US-6410746-B1 | ORGANOMETALLIC COMPOUND CONTAINING TRANSITION METAL | RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK, THE | 2002-06-25 | — | — | US | disclosed |
| EP-1173278-A1 | METAL CATALYSTS AND METHODS FOR MAKING AND USING SAME | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2002-01-23 | — | — | EP | disclosed |
| WO-2000064583-A1 | METAL CATALYSTS AND METHODS FOR MAKING AND USING SAME | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) | 2000-11-02 | — | — | WO | disclosed |
| US-3997525-A | Tetra-125 iodo-di-tyramine of digitalis derivative and process for making the same | BIO-TEC, INC. (US) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12582752-B2 | Medical device and method for manufacturing same | STS, DEGS1, HPSE | CES1 571/4885CES2 273/4885TSHR 1049/4885 |
| US-20020183535-A1 | Metal catalysts and methods for making and using same | COMT, SLC6A3, SLC6A2 | CES1 886/4885CES2 104/4885TSHR 101/4885 |
| US-20030130112-A1 | Solid support dirhodium catalyst compositions and methods for making and using same | DOHH, DHODH, HDHD5 | CES1 2584/4885CES2 2109/4885TSHR 2924/4885 |
| US-20030130536-A1 | Dirhodium catalyst compositions and methods for using same | DOHH, DNPH1, NOTUM | CES1 170/4885CES2 128/4885TSHR 4842/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.